Vaccine Research Market Size to grow by USD 21.4 billion between 2024-2028

Technavio, a leading provider of market research reports, has released its latest study on Vaccine Research Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges. Artificial Intelligence (AI) is revolutionizing the vaccine research market by transforming data into valuable insights that accelerate the discovery and development of new vaccines. By analyzing complex data sets, AI enables a deeper understanding of the diseases to be treated, optimizing clinical trial designs, and expediting vaccine development. AstraZeneca Plc is among the leading organizations leveraging AI across its Research and Development (R&D) activities. Through data collation, connection, and analysis, AstraZeneca gains a more comprehensive understanding of diseases, enabling the identification of higher probability drug targets. Additionally, AI tools facilitate real-time image analysis, aiding researchers in detecting genetic mutations and variations that could potentially impact vaccine development. Overall, AI's integration into vaccine research significantly enhances R&D productivity and efficiency.

Key Highlights

Growth Projections

The global vaccine research market  size is estimated to grow by USD 21.4 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.84% during the forecast period. High prevalence of infectious diseases is driving market growth, with a trend towards adoption of ai to speed up r and d of vaccines  However, high cost of vaccine research, development, and manufacturing  poses a challenge.Key market players include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., Creative Biogene, CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd..

Know what is trending in the market - Access a free sample report! 

Major Findings

• The vaccine research market holds significant importance due to the high prevalence of infectious diseases worldwide. These diseases pose a substantial threat to public health and necessitate continuous research and development of effective vaccines. Vaccines play a crucial role in preventing the spread of infectious diseases and saving lives. The market for vaccine research is driven by the increasing burden of infectious diseases, technological advancements, and government initiatives to ensure population health and safety.


• The vaccine market holds significant importance due to the continuous emergence of chronic infections that require novel vaccine solutions. Chronic infections pose a major health threat, often leading to long-term complications and high healthcare costs. Innovative vaccine research and development are essential to address these persistent health challenges and provide effective preventive measures for individuals and populations. Advancements in vaccine technology, such as mRNA and nanotechnology, offer promising avenues for the creation of novel vaccines to combat chronic infections and improve global health outcomes.


• The vaccine research market entails significant expenses in the discovery, development, and manufacturing processes. The high cost is attributed to the intricacy of vaccine production, which involves rigorous clinical trials and stringent regulatory compliance. Advancements in biotechnology and innovative research methods aim to streamline these processes and reduce costs, ensuring affordable and accessible vaccines for a global population.


• The vaccine research market faces significant challenges in ensuring the proper storage and handling of vaccines to maintain their efficacy and safety. Temperature control during transportation and storage is crucial, as many vaccines require specific conditions to remain effective. Improper handling, such as exposure to extreme temperatures or contamination, can render vaccines ineffective or even dangerous. Additionally, logistical challenges, including distribution and accessibility, particularly in remote or underserved areas, can hinder the successful implementation of vaccination programs. These issues necessitate ongoing research and investment in innovative solutions to address the complexities of vaccine storage, handling, and distribution.

Market Research Overview

The global life sciences tools and services market encompasses the revenue generation of manufacturers in the R&D sector, focusing on capital equipment, instruments, accessories, and consumables for pharmaceuticals, biotechnology, and laboratory diagnosis. Additionally, this market includes life sciences-related services such as contract research, manufacturing, and sales. According to Technavio, market expansion will be fueled by the aging population, with the global population over 60 years projected to rise significantly, increasing demand for healthcare solutions and diagnostic tools.

The Vaccine Research Market is experiencing significant growth, fueled by the High prevalence of infectious diseases. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

For insights on company offerings- Request a sample report!

Regional Insights

In the dynamic business landscape of healthcare, the vaccine research market represents a significant growth opportunity. This sector is driven by the continuous development of new vaccines to address global health concerns. Companies are investing heavily in research and development to bring innovative solutions to market, leveraging advanced technologies and collaborations to enhance their competitive edge. The market is expected to expand at a robust pace due to increasing demand for preventive healthcare and government initiatives to boost immunization programs.

Research Analysis Overview

The vaccine market encompasses a wide range of products, including Toxoid, Inactivated, Live-Attenuated, Conjugate, Recombinant, Subunit, Monovaccines, and Combination vaccines. Toxoid vaccines use toxins that have been modified to stimulate an immune response. Inactivated vaccines contain killed microorganisms, while Live-Attenuated vaccines use weakened forms. Conjugate vaccines link a polysaccharide antigen with a protein carrier to enhance immunity. Recombinant and Subunit vaccines use specific proteins or genes from a pathogen. Polio, Chickenpox, Hepatitis B, Influenza, Rotavirus, MMR, HPV, Tetanus, Diphtheria, and Pneumococcal vaccines are examples of these types. Vaccines address various physiological disorders such as Allergies, Cancer, and therapeutic vaccines are under development for pregnant individuals during the gestational age. Vaccine development involves Clinical trials to ensure safety and efficacy before distribution through Immunization programs. Polio vaccines, for instance, have significantly reduced polio cases worldwide, while HPV vaccines protect against certain types of cancer. Other vaccines, like Influenza and Pneumococcal vaccines, help prevent common illnesses.

About Technavio                                                                        

Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies. 

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/